| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Feb―21 |
Evolving immune evasion and transmissibility of SARS-CoV-2: The emergence of JN.1 variant and its global impact |
Guanyong Ou, Yang Yang, Shengjie Zhang, Shiyu Niu, Qingxian Cai, Yingxia Liu, Hongzhou Lu |
| 2 |
[GO] |
2023―Oct―29 |
Inhaled ciclesonide does not affect production of antibodies or elimination of virus in patients with COVID-19: Subanalysis of a multicenter, open-label randomized trial |
Manabu Suzuki, Akihiro Matsunaga, Tohru Miyoshi-Akiyama, Junko Terada-Hirashima, Kenji Sadamasu, Mami Nagashima, Jin Takasaki, Shinyu Izumi, Masayuki Hojo, Yukihito Ishizaka, Haruhito Sugiyama |
| 3 |
[GO] |
2023―Jun―15 |
Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases |
Meirong Wang, Juan Qi, Yujuan Liu |
| 4 |
[GO] |
2023―Apr―28 |
University students' living conditions during the COVID-19 pandemic and predictors of their subjective health views: A cross-sectional survey |
Kiyoshi Hotta, Yukihiro Mori, Makoto Aoike, Yukihiro Shigeno, Yuka Aoyama, Mamoru Tanaka, Hana Kozai, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 5 |
[GO] |
2023―Mar―21 |
Examination of the utility of the COVID-19 detection kit, TRC Ready<sup>®</sup> SARS-CoV-2 i for nasopharyngeal swabs |
Satoru Ishii, Moto Kimura, Tohru Miyoshi-Akiyama, Ataru Moriya, Masami Kurokawa, Erina Isaka, Junko Terada-Hirashima, Jin Takasaki, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama |
| 6 |
[GO] |
2023―Feb―25 |
Age distribution and disease severity of COVID-19 patients continued to change in a time-dependent manner from May 2021 to April 2022 in the regional core hospital in Japan |
Futoshi Kawaura, Takuya Kishi, Tadashi Yamamoto, Shiki Nakayama, Taku Goto, Reimi Tsurusawa, Toshio Katagiri, Kohei Yamanouchi, Ayako Matsuo, Naomi Kobayashi-Watanabe, Tomohiro Imamura, Yoshitaka Hirooka, Kuniyasu Takagi, Tsukuru Umemura, Kazuma Fujimoto, Shinichiro Hayashi, Ayako Takamori |
| 7 |
[GO] |
2023―Feb―24 |
A fast RT-qPCR system significantly shortens the time for SARS-CoV-2 nucleic acid test |
Hongjie Dong, Kundi Zhang, Junmei Zhang, Yumeng Xiao, Fengyu Zhang, Maofeng Wang, Hongwei Wang, Guihua Zhao, Shiling Xie, Xiaohong Xie, Wei Hu, Kun Yin, Lichuan Gu |
| 8 |
[GO] |
2023―Feb―01 |
Factors affecting health-related quality of life among firefighters during the COVID-19 pandemic: A single-center study |
Yukihiro Shigeno, Yukihiro Mori, Kiyoshi Hotta, Yuka Aoyama, Mamoru Tanaka, Hana Kozai, Makoto Aoike, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 9 |
[GO] |
2022―Oct―25 |
Impact of inhaled ciclesonide on asymptomatic or mild COVID-19: A randomized trial |
Junko Terada-Hirashima, Manabu Suzuki, Yoshie Tsujimoto, Yoichiro Hamamoto, Yukari Uemura, Kenji Tsushima, Hideki Inoue, Shigeru Komatsu, Zenya Saito, Ryuta Tsuzuki, Masaki Okamoto, Yasuo To, Kyoji Moriya, Sadako Yoshizawa, Masahide Tanaka, Toshitaka Muto, Ayako Mikami, Jin Takasaki, Shinyu Izumi, Norio Ohmagari, Masayuki Hojo, Wataru Sugiura, Haruhito Sugiyama |
| 10 |
[GO] |
2022―Oct―06 |
Cross-infection risks of SARS-CoV-2 while playing catch using a baseball: Creating a safe sporting environment during the COVID-19 pandemic |
Yoko Iio, Yukihiro Mori, Masato Tsurudome, Morihiro Ito |
| 11 |
[GO] |
2022―Sep―05 |
Relaxation of all-case reporting of COVID-19 cases in Japan |
Kenji Karako |
| 12 |
[GO] |
2022―Aug―20 |
Prevalence of SARS-CoV-2 antibodies among university athletic club members: A cross-sectional survey |
Yukihiro Mori, Mamoru Tanaka, Hana Kozai, Kiyoshi Hotta, Yuka Aoyama, Yukihiro Shigeno, Makoto Aoike, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 13 |
[GO] |
2022―Jun―25 |
Evaluation of Japanese university students' perception of smoking, interest in quitting, and smoking behavior: An examination and public health challenges during the COVID-19 pandemic |
Makoto Aoike, Yukihiro Mori, Kiyoshi Hotta, Yukihiro Shigeno, Yuka Aoyama, Mamoru Tanaka, Hana Kouzai, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 14 |
[GO] |
2022―Jun―24 |
Efficacy and safety of sotrovimab for vaccinated or unvaccinated patients with mild-to-moderate COVID-19 in the omicron era |
Takehiro Izumo, Nobuyasu Awano, Naoyuki Kuse, Keita Sakamoto, Kohei Takada, Yutaka Muto, Kazushi Fujimoto, Ayae Saiki, Yu Ito, Hiroaki Ota, Minoru Inomata |
| 15 |
[GO] |
2022―May―05 |
Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? |
Guangbin Chen, Hongzhou Lu |
| 16 |
[GO] |
2022―Apr―03 |
Antibody response of smokers to the COVID-19 vaccination: Evaluation based on cigarette dependence |
Yukihiro Mori, Mamoru Tanaka, Hana Kozai, Kiyoshi Hotta, Yuka Aoyama, Yukihiro Shigeno, Makoto Aoike, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito |
| 17 |
[GO] |
2022―Mar―08 |
Effect of corticosteroids in patients with COVID-19 early stage pneumonia and risk of disease progression: An uncharted territory |
Anabel Franco-Moreno, María Soledad Acedo-Gutiérrez, Rodolfo Romero-Pareja, Juan Torres-Macho |
| 18 |
[GO] |
2022―Mar―08 |
Waning COVID-19 vaccine effectiveness in Japan |
Junko Kurita, Tamie Sugawara, Yasushi Ohkusa |
| 19 |
[GO] |
2022―Mar―08 |
The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials |
Basel Abdelazeem, Ahmed K. Awad, Merihan A. Elbadawy, Nouraldeen Manasrah, Bilal Malik, Amman Yousaf, Sarah Alqasem, Sandi Banour, Sarah Magdy Abdelmohsen |
| 20 |
[GO] |
2022―Jan―14 |
Drug discovery to treat COVID-19 two years after its outbreak |
Jianjun Gao, Fusheng Sun |
| 21 |
[GO] |
2022―Jan―14 |
Pneumothorax and pneumomediastinum in patients with COVID-19: A retrospective study from tertiary care institute in India |
Saurav Sekhar Paul, Bhavesh Mohan Lal, Animesh Ray, Ved Prakash Meena, Rohit Kumar Garg, Pawan Tiwari, Prashant Sirohiya, Saurabh Vig, Sushma Bhatnagar, Anant Mohan, Surabhi Vyas, Naveet Wig |
| 22 |
[GO] |
2021―Dec―29 |
Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): A review |
Yayun Xu, Li Yang, Longfei Wang, Feihu Chen |
| 23 |
[GO] |
2021―Oct―29 |
Post COVID-19 sequelae: A prospective observational study from Northern India |
Shivdas Naik, Soumendra Nath Haldar, Manish Soneja, Netto George Mundadan, Prerna Garg, Ankit Mittal, Devashish Desai, Praveen Kumar Trilangi, Sayan Chakraborty, Nazneen Nahar Begam, Bisakh Bhattacharya, Ganesh Maher, Niranjan Mahishi, Chaithra Rajanna, Swasthi S Kumar, Bharathi Arunan, J Kirtana, Ankesh Gupta, Diksha Patidar, Parul Kodan, Prayas Sethi, Animesh Ray, Pankaj Jorwal, Arvind Kumar, Neeraj Nischal, Sanjeev Sinha, Ashutosh Biswas, Naveet Wig |
| 24 |
[GO] |
2021―Oct―27 |
Role of systemic corticosteroids in preventing hypoxia among patients with mild COVID-19: An observational study |
Anivita Aggarwal, Ankit Mittal, Manish Soneja, Sujay Halkur Shankar, Shivdas Naik, Parul Kodan, Neeraj Nischal, Pankaj Jorwal, Animesh Ray, Naveet Wig |
| 25 |
[GO] |
2021―Oct―27 |
Antiviral effect of electrolyzed reduced water on SARS-CoV-2 |
Yoshinao Okajima, Masahiro Okajima, Mitsuo Ikeda, Yuko Wada, Ken-ichi Shimokawa, Fumiyoshi Ishii |
| 26 |
[GO] |
2021―Oct―25 |
Does immunosuppressive property of non-steroidal anti-inflammatory drugs (NSAIDs) reduce COVID-19 vaccine-induced systemic side effects? |
Itsuro Kazama, Momono Senzaki |
| 27 |
[GO] |
2021―Aug―25 |
India and management of COVID-19: A case study on published guidelines |
Rohit Kumar, Ankit Mittal, Shreya Das Adhikari, Eram Afroz, Nitin Gupta |
| 28 |
[GO] |
2021―Jul―18 |
Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021 |
Cui Xiaoni, Wang Pengxiang, Wei Zhun |
| 29 |
[GO] |
2021―Jul―05 |
Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19 |
Qian Li, Jun Wang, Yang Tang, Hongzhou Lu |
| 30 |
[GO] |
2021―Jul―05 |
Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India |
Neha Chopra, Mohit Chowdhury, Anupam K Singh, Khan MA, Arvind Kumar, Piyush Ranjan, Devashish Desai, Naveet Wig |
| 31 |
[GO] |
2021―Jul―05 |
Antimicrobial resistance and COVID-19 syndemic: Impact on public health |
Ashima Jain Vidyarthi, Arghya Das, Rama Chaudhry |
| 32 |
[GO] |
2021―Feb―27 |
Clinical profile and outcomes of asymptomatic vs. symptomatic travellers diagnosed with COVID-19: An observational study from a coastal town in South India |
Nitin Gupta, Anupa John, Mohammed Safeer Kokkottil, Muralidhar Varma, Shashikiran Umakanth, Kavitha Saravu |
| 33 |
[GO] |
2021―Feb―18 |
Multidrug treatment for COVID-19 |
Masashi Ohe, Ken Furuya, Houman Goudarzi |
| 34 |
[GO] |
2020―Dec―30 |
Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2 |
Ines ElBini Dhouib |
| 35 |
[GO] |
2020―Dec―29 |
COVID-19 in patients living with human immunodeficiency virus (HIV) infection: Challenges and way-forward |
Manasvini Bhatt, Manish Soneja, Nitin Gupta |
| 36 |
[GO] |
2020―Dec―29 |
Approach to acute febrile illness during the COVID-19 pandemic |
Manasvini Bhatt, Manish Soneja, Nitin Gupta |
| 37 |
[GO] |
2020―Dec―29 |
Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic |
Yaser Pashaei |
| 38 |
[GO] |
2020―Oct―28 |
Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis? |
Mir S. Adil, S. Priya Narayanan, Payaningal R. Somanath |
| 39 |
[GO] |
2020―Sep―07 |
Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19 |
Shweta Sinha, Alka Sehgal, Rakesh Sehgal |
| 40 |
[GO] |
2020―Sep―07 |
Laboratory diagnosis of COVID-19 in Africa: availability, challenges and implications |
Elijah Kolawole Oladipo, Ayodeji Folorunsho Ajayi, Aduragbemi Noah Odeyemi, Olawumi Elizabeth Akindiya, Emmanuel Tayo Adebayo, Ayomide Samuel Oguntomi, Moyosoluwa Precious Oyewole, Esther Moradeyo Jimah, Abayomi Adio Oladipo, Olumuyiwa Elijah Ariyo, Bukola Bisola Oladipo, Julius Kola Oloke |
| 41 |
[GO] |
2020―Sep―07 |
Review of current clinical management guidelines for COVID-19 with special reference to India |
Rohit Kumar, Kutty Sharada Vinod, Ankit Mittal, Shreya Das Adhikari, Nitin Gupta |
| 42 |
[GO] |
2020―Jul―14 |
Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies |
Bushra Hassan Marouf, Kawa Dizaye |
| 43 |
[GO] |
2020―Jul―14 |
Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research |
Jinjing Wang, Fanghua Qi |
| 44 |
[GO] |
2020―Jun―24 |
Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy? |
Itsuro Kazama |
| 45 |
[GO] |
2020―Jun―15 |
Can mesenchymal stem cell therapy be the interim management of COVID-19? |
Chitra Bamba, Surinder P. Singh, Sangeeta Choudhury |
| 46 |
[GO] |
2020―May―05 |
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far? |
Yuanyuan Zhang, Yanyan Zhong, Lin Pan, Jing Dong |
| 47 |
[GO] |
2020―Apr―24 |
Treatment of SARS-CoV-2: How far have we reached? |
Waquar Ahsan, Shamama Javed, Mohammed Al Bratty, Hassan A. Alhazmi, Asim Najmi |
| 48 |
[GO] |
2020―Apr―20 |
Is GSK3β a molecular target of chloroquine treatment against COVID-19? |
Mohammed Noor Embi, Nagesswary Ganesan, Hasidah Mohd Sidek |
| 49 |
[GO] |
2020―Mar―25 |
Facts and reflections on COVID-19 and anti-hypertensives drugs |
Gustavo H. Marin |
| 50 |
[GO] |
2020―Mar―07 |
Discovering drugs to treat coronavirus disease 2019 (COVID-19) |
Liying Dong, Shasha Hu, Jianjun Gao |
|
